Umbilical cord-derived mesenchymal stem cells (Alliancells/Zhongyuan Union)

N/A

Report date: 2023/01/12 15:28:47

Base Information

Drug NameUmbilical cord-derived mesenchymal stem cells (Alliancells/Zhongyuan Union)

Drug Alias NameUC-MSC - Alliancells Bioscience

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLiver CirrhosisArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesAlliancells Bioscience Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlliancells Bioscience Corporation Ltd

Active IndicationsN/A

Inactive IndicationsLiver CirrhosisArthritis, Rheumatoid

Other Information

ATC CodeN/A